Articles

The Longer the Wait, The Smaller the Opportunity for Novavax

The delay in FDA approval is making the opportunity smaller for Novavax, but the opportunity still remains. NVAX stock is a hold. More

3 Hot Stocks That Could Be Set for a Cold Shower

Rising inflation, high energy prices and geopolitical turmoil have become this year's dominating themes. Here are three hot stocks that could see declines in the rest of the year. More

Microsoft Stock Is the One to Own in 2022 and Beyond

Besides a solid product portfolio, Microsoft is making strategic acquisitions to help its business grow. MSFT stock is a buy. More

3 Dow Stocks to Buy for Q2 and Beyond

Sometimes investors ignore the Dow Jones, but often times some of these Dow stocks can be the best ones to be long. More

Build Up Your Built World Portfolio with Matterport Stock

MTTR stock holders are having their patience tested, but they should prevail in the end as Matterport masters digital-twin technology. More

3 Most-Shorted Stocks That Are Big-Time Buys

If there's one or rather three spots to ignore a market that's under pressure, it may just be these most-shorted stocks. More

Wait for C3.AI to Get Back to $26 Before Buying AI Stock

There's reasons to see C3.ai coming out the other side stronger, but right now AI stock is better set up for the shorts. More